1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabine

Technology appraisal guidance [TA440] Published: 26 April 2017

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

History

A list of downloadable documents created during development.

Final appraisal determination

  • Final appraisal determination  
  • Final appraisal determination document PDF 461 KB 28 March 2017  
  • Committee papers PDF 1.57 MB 28 March 2017  
  • Public committee slides PDF 198 KB 28 March 2017  

Draft guidance: 1

  • Draft guidance: 1  
  • Appraisal consultation document PDF 343 KB 15 November 2016  
  • Committee papers PDF 8.51 MB 12 April 2017  
  • Public committee slides PDF 103 KB 12 April 2017  
  • Public committee slides PDF 223 KB 12 April 2017  

Invitation to participate

  • Equality impact assessment (Scoping) PDF 62 KB 25 February 2016  
  • Final scope PDF 103 KB 25 February 2016  
  • Final matrix PDF 100 KB 25 February 2016  
  • NICE's response to comments on the draft scope and provisional matrix PDF 143 KB 25 February 2016  

Draft scope documents

  • Draft scope (pre-referral) PDF 137 KB 04 February 2016  
  • Provisional matrix (pre-referral) PDF 101 KB 04 February 2016